Assignee
VANDER JAGT DAVID L
US·2 granted patents·3 pending applications·15 citations·filing 2005–2007
Top patents by PatentIndex Score
5 records- 0187US8841326B2Therapeutic curcumin derivativesVANDER JAGT DAVID L·Filed 2006·Granted Sep 23, 2014·13 cites·13 claims
- 0279US8980954B2Substituted cis- and trans-stilbenes as therapeutic agentsVANDER JAGT DAVID L·Filed 2007·Granted Mar 17, 2015·2 cites·16 claims
- 0347US2005228038A111-Beta hydroxysteroid dehydrogenase type 1 inhibitors as anti-obesity/anti-diabetes compounds and 17-beta hydrosteroid dehydrogenase type I inhibitors as useful agents for the treatment of cancers, especially breast cancerVANDER JAGT DAVID L·Filed 2005·Application pending·0 cites
- 0441US2006258752A1Method and compounds for cancer treatment utilizing NFkB as a direct or ultimate target for small molecule inhibitorsVANDER JAGT DAVID L·Filed 2005·Application pending·0 cites
- 0537US2006276536A1Cancer treatment using curcumin derivativesVANDER JAGT DAVID L·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when VANDER JAGT DAVID L files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →